Oral Prednisone in Treating LCH of Bone in Childhood and Adolescence
Conditions: Langerhans Cell Histiocytosis of Bone Interventions: Drug: Prednisone Sponsors: Shanghai Changzheng Hospital; First Affiliated Hospital of Zhejiang University; Peking University Third Hospital; National Sun Yat-sen University; Beijing Children ' s Hospital; Henan Cancer Hospital; Tianjin Hospital; First Affiliated Hospital, Sun Yat-Sen University; Second Hospital of Jilin University; Peking University People ' s Hospital; Jinling hospital Nanjing, Jiangsu, China; The First Affiliated Hospital of Nanchang University; The Third Affiliated Hospital of Southern Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Childhood Cancer | Children | China Health | Histiocytosis | Hospitals | Langerhans Cell Histiocytosis (LCH) | Oral Cancer | Prednisone | Research